Key outcomes: At the 10-year mark, patients who underwent metabolic surgery had significantly better outcomes: 32% lower risk of death 35% lower risk of major adverse cardiovascular events (MACE) , including heart attack, heart failure, or stroke 47% lower risk of chronic kidney disease (CKD) 54% lower risk of diabetes-related retinopathy (eye damage) The 10-year cumulative incidence of all-cause mortality was 9.0% (95% CI 6.810.8%) in the metabolic surgery group, compared with 12.4% (95% CI 9.915.2%) in the GLP-1RA group (adjusted hazard ratio 0.68, 95% CI 0.480.96
How does the Microdose GLP-1 Protocol differ from standard-dose semaglutide
NAC is generally well-tolerated in healthy adults at typical supplemental doses, but there are real considerations
The second is Ibotta, Inc., which started as a mobile app offering cash back on everyday purchases and has since expanded its platform to include a wide variety of grocery items
Rajagopalan, S., Andreeva, A., Teufel, D